• News

"Systemic Tx Offers Better Outcomes in Severe Uveitis" - Kristin Jenkins

  • Medpage Today
  • New York, NY
  • (May 07, 2017)

Systemic therapy with oral corticosteroids and immunosuppression preserved vision better over the long term than regional implant therapy in patients with severe uveitis, according to a 7-year follow-up study. "The clinical implications based on these results is that for many patients – probably most – systemic therapy would be a better choice," noted co-author Douglas Jabs, MD, MBA, director, Mount Sinai New York Eye and Ear Vision Institute at The Mount Sinai Hospital, told MedPage Today. "They have better visual outcomes long-term, fewer ocular side effects, and no apparent significant increase in the risk of systemic side effects, except for the greater use of antibiotics.:

- Douglas A. Jabs, MD, MBA, Professor, Ophthalmology, Medicine, Icahn School of Medicine at Mount Sinai, Director, Uveitis Division, Mount Sinai Hospital, Director, Mount Sinai/NewYork Eye and Ear Vision Research Institute

Learn more

Additional Coverage:
News Medical
Medical Express